Researchers and otolaryngologists are considering the use of biologic agents to manage allergic rhinitis (AR), a common, non-life-threatening condition.
![](https://www.enttoday.org/wp-content/uploads/2022/09/shutterstock_1549234169-145x85.jpg)
In the past six months, I’ve detected duplicated images in multiple submitted articles, equating to more than 40% of the articles I reviewed.